These Three Toilets Detection Health Technologies Will Be Clinically Tested In The US, Izrael a Japonsko

These Three Toilets Detection Health Technologies Will Be Clinically Tested In The US, Izrael a Japonsko

Israeli digital health startup OutSense has been awarded a number of patents for key innovations in IoT technology, according to foreign media reports on 23 červen. The technology gains life-saving medical insights by analysing human excrement. Společnost podala řadu tří patentů pokrývajících prvky svého senzoru pro lékařské toalety.

Three Toilets Detection Health Technologies

The first OutSense toilets detection health technologies is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet to determine the optical signature of hidden blood in faeces. Patents for this technology have been granted in the US, Evropa, Japonsko a Čína.

A second toilets detection health technologies has been granted in Europe and applications for this patent are pending in other countries. It allows effective analysis of the many components of faeces and the spatial distribution of blood traces. On the basis of this analysis, Technologie OutSense dokáže identifikovat zdroj krve podél gastrointestinálního traktu.

A third patent is pending for a technology that detects the dehydrated composition of urine through the analysis of urine and faeces.

Podle CEO OutSense Yfat Scialom, who predicts that “s explozí digitální medicíny, this kind of monitoring will become the norm”, OutSense says that the technology already approved and pending approval will provide broad protection for a person’s health by non-invasively extracting faeces and hidden blood from the urine. Hidden blood is essential for detecting colorectal cancer, zánětlivé onemocnění střev a infekce močových cest.

Its solution consists of a multispectral optical sensor, světelný zdroj a autonomní stínící zařízení, které zahrnuje WiFi připojení. The device scans human excrement, identifies the optical footprint of faecal and urine components, sends the data to an AI-based cloud analysis and then provides indications of various diseases with great precision.

OutSense has developed tools to diagnose abnormalities in human excreta. Informace získané z odebrané krve, v kombinaci s další analýzou doby od krvácení do vylučování, poskytuje podrobnosti o patologii krvácení. Its specific patterns can determine whether the bleeding is from a fissure or haemorrhoid, from a polyp, a tumour or from an ulcer.

At the beginning of June, OutSense oznámil, že CommuniCare, velká zdravotnická společnost s více než 90 healthcare facilities in the US, zahájí pilotní testování své technologie ještě letos. Kromě tohoto pilota, OutSense also plans to conduct clinical trials in Israel and Japan.

Navštivte další zprávy na Viga.cc novinky